There's no reason 2018 can't be the year you finally achieve your goal of buying a new home. Licensed real estate professional Victoria Shtainer joins Cheddar with a guide of how to approach making the milestone purchase in the new year. She says the new tax bill is causing uncertainty in the market, and that such volatility can be good for buyers.
Then, Shtainer gives her tips on what to consider before buying and planning for a move. She says it's important to put in time raking your priorities so you know what to keep in mind when beginning your search. She also discusses why she thinks it's key to keep your paperwork and finances in order so you're prepared to act quickly.
Finally, we hone in on planning a potential move to New York City. Shtainer says to plan on downsizing, beware of fees, and to always visit the apartment building before signing anything. With NYC home prices becoming more affordable, she expects the market to heat up in the new year.
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
